US FDA pre submission meetings are part of the Q-Submission Program. It allows medical device manufacturers to obtain structured, written feedback and optional meetings with FDA reviewers. These meetings are conducted before submitting applications, such as 510(k), De...
EU MDR medical device labelling is critically important because it ensures patient safety, regulatory compliance, and EU market access. Labels provide essential information, such as device identification, manufacturer details, usage instructions, warnings, and...
US FDA 510(k) consultants help medical device companies navigate complex regulatory requirements and avoid costly mistakes during submission. Their expertise ensures that documentation, testing, and predicate device comparisons are accurate and aligned with FDA...
Medical device equivalence is a regulatory concept under the EU Medical Device Regulation (MDR). It allows a manufacturer to rely on the clinical data of an already marketed device to support the safety and performance of a new device. However, they must demonstrate...
The EU AI Act introduces a new compliance layer for AI-enabled medical devices in Europe. It requires manufacturers to meet both EU MDR/IVDR and AI Act obligations. High-risk AI medical devices must now address AI-specific requirements, such as data governance, risk...